Castillo, Shara N.

HRN: 18-94-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
AMPICILLIN 1GM (VIAL)
12/15/2022
12/19/2022
IVTT
2grams
Q6hrs
Prophylaxis For Chorioamnionitis
Waiting Final Action 
12/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/15/2022
12/22/2022
IV
500mg
Q8
Msaf
Waiting Final Action 
12/16/2022
CEFUROXIME 500MG (TAB)
12/16/2022
12/23/2022
ORAL
500mg
BID
Perineorrhaphy; MSAF
Waiting Final Action 
12/16/2022
METRONIDAZOLE 500MG (TAB)
12/16/2022
12/23/2022
ORAL
500mg
TID
MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: